Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 13,883	$ 16,418	$ 41,321	$ 50,834
Less provision for bad debts of Healthcare Facilities Segment	184	213	321	1,461
Net revenues	13,699	16,205	41,000	49,373
Costs and Expenses
Cost of goods sold	5,523	5,614	15,592	15,582
Salaries, wages and benefits	5,872	7,675	17,476	23,918
Provision for bad debts of Specialty Pharmacy Segment	126	69	342	429
Supplies	455	647	1,373	2,486
Purchased services	692	761	2,113	2,510
Other operating expenses	1,194	1,958	4,015	6,125
Rent and lease expense	142	191	409	582
Depreciation and amortization	466	477	1,376	1,356
Operating Loss	(771)	(1,187)	(1,696)	(3,615)
Other Income, (Expense):
Gain on sale of assets	2	5	3,019	12
Loss on extinguishment of debt - net	0	0	(243)	0
Interest expense - net	(129)	(211)	(507)	(637)
Earnings (Loss) from Continuing Operations before income taxes	(898)	(1,393)	573	(4,240)
Income tax expense (benefit)	(8)	(1)	(236)	6,851
Earnings (Loss) from Continuing Operations	(890)	(1,392)	809	(11,091)
Earnings (Loss) from Discontinued Operations, net of tax	(135)	(443)	4,287	(1,758)
Net Earnings (Loss)	(1,025)	(1,835)	5,096	(12,849)
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (1,025)	$ (1,835)	$ 5,096	$ (12,849)
Continuing Operations:
Basic	$ (0.10)	$ (0.15)	$ 0.09	$ (1.17)
Diluted	(0.10)	(0.15)	0.09	(1.17)
Discontinued Operations:
Basic	(0.01)	(0.05)	0.46	(0.19)
Diluted	(0.01)	(0.05)	0.45	(0.19)
Net Earnings (Loss):
Basic	(0.11)	(0.19)	0.54	(1.36)
Diluted	$ (0.11)	$ (0.19)	$ 0.54	$ (1.36)
Weighted-Average Common Shares Outstanding:
Basic	9,334	9,443	9,408	9,443
Diluted	9,334	9,443	9,429	9,443